Theranexus (XPAR:ALTHX) Tax Rate % : 15.56% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Theranexus Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Theranexus's Tax Expense for the six months ended in Dec. 2023 was €-0.59 Mil. Theranexus's Pre-Tax Income for the six months ended in Dec. 2023 was €-3.77 Mil. Therefore, Theranexus's Tax Rate % for the quarter that ended in Dec. 2023 was 15.56%.

Theranexus Tax Rate % Historical Data

The historical data trend for Theranexus's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theranexus Tax Rate % Chart

Theranexus Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Rate %

Get a 7-Day Free Trial

26.75

17.16

17.74

9.66

10.51

Theranexus Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Tax Rate %	Get a 7-Day Free Trial												15.61	0.54	19.37	5.59	15.56

Theranexus Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Theranexus's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2023 )	/	Pre-Tax Income (A: Dec. 2023 )
	=	-0.802	/	-7.63
	=	10.51 %

Theranexus's Tax Rate % for the quarter that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2023 )	/	Pre-Tax Income (Q: Dec. 2023 )
	=	-0.586	/	-3.767
	=	15.56 %

Theranexus Tax Rate % Related Terms

Thank you for viewing the detailed overview of Theranexus's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Theranexus (XPAR:ALTHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

3VG:Germany

Address

60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008

Website

https://www.theranexus.com

Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

Theranexus (XPAR:ALTHX) Headlines

No Headlines